Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2.
By Joan L. Walker, M. Piedmonte, N. Spirtos, S. Eisenkop, J. Schlaerth, Robert S. Mannel, G. Spiegel, R. Barakat, M. Pearl, Sudarshan K. Sharma. Journal of Clinical Oncology, 2009
1,123 citations recorded by the source corpus.
Subfields: Obstetrics and Gynecology, Surgery
View Paper: https://www.semanticscholar.org/paper/894a91cd2fffbe4129e321b47af2fdffeabe5017
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Obstetrics and Gynecology
- N. Colombo
- Jonathan A. Ledermann
- Remi A. Nout
- F. Amant
- C. Sessa
- D. Querleu
- Carien L. Creutzberg
- M. Mirza
Citations in the corpus
- ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. (2015, positive): “The largest randomised trial comparing laparoscopy to laparotomy is the LAP2 study [73], which was designed to compare laparoscopy versus laparotomy for comprehensive surgical staging and management of stage I–IIA uterine cancer, including hysterectomy, salpingo-oophorectomy, pelvic cytology and pel”
- Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. (2012, neutral): “There was a significant decrease in histologic identification of any pelvic and para-aortic lymph nodes; however, this did not translate into a significant difference in final stage or identification of metastatic disease when comparing laparoscopy with laparotomy.(11) In this report, we compare rec”